Two-year, prospective, multicenter study of the use of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in the clinical setting in France
about
Short-term outcomes in patients with branch retinal vein occlusion who received intravitreal aflibercept with or without intravitreal ranibizumab.Aflibercept in macular edema secondary to retinal vein occlusion: A real life study.Real-life clinical data for dexamethasone and ranibizumab in the treatment of branch or central retinal vein occlusion over a period of six months.Reply to a letter to the editor: Dexamethasone intravitreal implant in retinal vein occlusion: real-life data from a prospective, multicenter clinical trial.Comparison of one and three initial monthly intravitreal ranibizumab injection in patients with macular edema secondary to branch retinal vein occlusion
P2860
Two-year, prospective, multicenter study of the use of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in the clinical setting in France
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Two-year, prospective, multice ...... the clinical setting in France
@ast
Two-year, prospective, multice ...... the clinical setting in France
@en
type
label
Two-year, prospective, multice ...... the clinical setting in France
@ast
Two-year, prospective, multice ...... the clinical setting in France
@en
prefLabel
Two-year, prospective, multice ...... the clinical setting in France
@ast
Two-year, prospective, multice ...... the clinical setting in France
@en
P2093
P2860
P1476
Two-year, prospective, multice ...... the clinical setting in France
@en
P2093
Laurent Kodjikian
Marie-Eve Velard
Richard Leaback
Sybil Pinchinat
Vincent Gualino
P2860
P2888
P304
P356
10.1007/S00417-016-3394-Y
P577
2016-06-11T00:00:00Z